Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001213900-24-112773
Filing Date
2024-12-26
Accepted
2024-12-26 19:20:39
Documents
1
Period of Report
2024-12-20

Document Format Files

Seq Description Document Type Size
1 ownership.html 4  
1 ownership.xml 4 10592
  Complete submission text file 0001213900-24-112773.txt   12728
Mailing Address 1450 2ND STREET SUITE 247 SANTA MONICA CA 90401
Business Address
Graf James A (Reporting) CIK: 0001519672 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-40427 | Film No.: 241581997

Mailing Address 3001 DAIMLER ST, SANTA ANA CA 92705
Business Address 3001 DAIMLER ST, SANTA ANA CA 92705 (949) 396-6830
NKGen Biotech, Inc. (Issuer) CIK: 0001845459 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)

Mailing Address C/O GRAF ACQUISITION CORP. IV 1790 HUGHES LANDING BLVD. THE WOODLANDS TX 77380
Business Address C/O GRAF ACQUISITION CORP. IV 1790 HUGHES LANDING BLVD. THE WOODLANDS TX 77380 (346) 442-0819
Graf Acquisition Partners IV LLC (Reporting) CIK: 0001862622 (see all company filings)

State of Incorp.: DE
Type: 4 | Act: 34 | File No.: 001-40427 | Film No.: 241581998